• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对多种病症调整健康状态效用值:巴西的真实世界EQ-5D-3L数据建模

Adjusting Health State Utility Values for Multiple Conditions: Real-World EQ-5D-3L Data Modeling in Brazil.

作者信息

da Costa Milene Rangel, Dos Santos Júnior Bráulio, da Silva Santos Marisa

机构信息

Centre of Health Technology Assessment, National Institute of Cardiology, Rio de Janeiro, Brazil.

Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

Pharmacoecon Open. 2025 May 31. doi: 10.1007/s41669-025-00586-y.

DOI:10.1007/s41669-025-00586-y
PMID:40450115
Abstract

BACKGROUND AND OBJECTIVE

Decision analytical models are typically included in health economic evaluations to represent clinical pathways and enable the estimation of clinical and economic outcomes of health technologies. Clinical effects are frequently measured in terms of health-related quality of life and expressed as utility values. It is not rare that a health state in an analytical model simultaneously comprises more than one health condition. In this situation, the utility of each coexisting health condition could be combined using the additive, multiplicative, minimum, or adjusted decrement estimator (ADE) methods. However, there is no consensus about the best approach. This study aimed to compare different methods to estimate utility values for health states in which patients carry more than one health condition using data from the Brazilian population.

METHODS

Data were obtained from a multicentric cross-sectional evaluation study conducted in Brazil. Individuals completed the EQ-5D-3L questionnaire, a generic preference-based instrument that is used to obtain utility values, and were requested to disclose if they had any health conditions. Utilities were obtained according to the Brazilian value set. Four methods for adjusting joint utilities were tested: additive, multiplicative, minimum, and ADE. Observed and estimated utility values were compared for accuracy and bias.

RESULTS

A total of 5774 individuals were included in the analysis. The utility score (mean ± SE) was 0.8235 ± 0.1717. Lower utility scores were associated with an increased number of comorbidities, reaching 0.467 ± 0.192 for individuals with seven conditions. The minimum method produced accurate utility estimates for individuals with two simultaneous health conditions. For health states with more than two conditions, the multiplicative method presented more accurate estimates. Overall, fixing the baseline utility equal to the mean utility of healthy individuals produced less biased estimates compared with a baseline utility equal to 1.

CONCLUSION

Depending on the utility data available and the number of concomitant conditions, different adjustment methods could be used that produce accurate estimates. For the adjustment of Brazilian utility values for health states with comorbidities, the minimum and multiplicative methods should be preferred if two or more than two conditions are present, respectively.

摘要

背景与目的

决策分析模型通常包含在卫生经济评估中,以呈现临床路径并估算卫生技术的临床和经济结果。临床效果常依据与健康相关的生活质量来衡量,并以效用值表示。在分析模型中,一种健康状态同时包含不止一种健康状况的情况并不罕见。在这种情形下,每种共存健康状况的效用可使用相加、相乘、最小值或调整减量估计器(ADE)方法进行合并。然而,对于最佳方法尚无共识。本研究旨在利用巴西人群的数据,比较估算患有不止一种健康状况的患者健康状态效用值的不同方法。

方法

数据取自巴西开展的一项多中心横断面评估研究。个体完成EQ-5D-3L问卷,这是一种基于偏好的通用工具,用于获取效用值,并被要求披露其是否患有任何健康状况。根据巴西价值集获取效用值。测试了四种调整联合效用的方法:相加、相乘、最小值和ADE。比较观察到的和估计的效用值的准确性和偏差。

结果

共有5774名个体纳入分析。效用得分(均值±标准误)为0.8235±0.1717。较低的效用得分与共病数量增加相关,患有七种疾病的个体效用得分达到0.467±0.192。最小值方法对同时患有两种健康状况的个体产生了准确的效用估计。对于患有两种以上疾病的健康状态,相乘方法给出了更准确的估计。总体而言,与将基线效用设定为1相比,将基线效用设定为健康个体的平均效用产生的偏差估计更少。

结论

根据可用的效用数据和伴随状况的数量,可使用不同的调整方法以产生准确的估计。对于合并症健康状态的巴西效用值调整,如果存在两种或两种以上状况,分别应优先选择最小值和相乘方法。

相似文献

1
Adjusting Health State Utility Values for Multiple Conditions: Real-World EQ-5D-3L Data Modeling in Brazil.针对多种病症调整健康状态效用值:巴西的真实世界EQ-5D-3L数据建模
Pharmacoecon Open. 2025 May 31. doi: 10.1007/s41669-025-00586-y.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.使用通用和特定疾病健康相关生活质量测量指标进行 NICE 决策制定:系统评价、统计建模和调查。
Health Technol Assess. 2014 Feb;18(9):1-224. doi: 10.3310/hta18090.
10
Sexual Harassment and Prevention Training性骚扰与预防培训

本文引用的文献

1
Estimating Joint Health State Utility Algorithms Under Partial Information.在部分信息下估算联合健康状态效用算法。
Value Health. 2023 May;26(5):742-749. doi: 10.1016/j.jval.2022.09.009. Epub 2022 Oct 26.
2
Estimating Joint Health Condition Utility Values.估算关节健康状况效用值。
Value Health. 2019 Apr;22(4):482-490. doi: 10.1016/j.jval.2018.09.2843. Epub 2019 Feb 22.
3
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report.
健康状态效用值在成本效果模型中的识别、评价和应用:ISPOR 疗效研究实践报告
Value Health. 2019 Mar;22(3):267-275. doi: 10.1016/j.jval.2019.01.004.
4
Estimating Health State Utility Values for Comorbidities.估算共病的健康状态效用值。
Pharmacoeconomics. 2017 Dec;35(Suppl 1):89-94. doi: 10.1007/s40273-017-0551-z.
5
Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study.巴西EQ-5D-3L健康状态评估:一项饱和度研究的结果
Med Decis Making. 2016 Feb;36(2):253-63. doi: 10.1177/0272989X15613521. Epub 2015 Oct 22.
6
Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods.比较使用 5 种不同方法估计的合并健康状况的 EQ-5D 评分。
Med Care. 2012 May;50(5):452-9. doi: 10.1097/MLR.0b013e318234a04a.
7
Estimating health state utility values for comorbid health conditions using SF-6D data.利用 SF-6D 数据估算合并症健康状况的健康状态效用值。
Value Health. 2011 Jul-Aug;14(5):740-5. doi: 10.1016/j.jval.2010.12.011. Epub 2011 May 31.
8
Predicting utility for joint health states: a general framework and a new nonparametric estimator.预测关节健康状况的效用:一个通用框架和一个新的非参数估计器。
Med Decis Making. 2010 Sep-Oct;30(5):E29-39. doi: 10.1177/0272989X10374508. Epub 2010 Jul 19.
9
Populating an economic model with health state utility values: moving toward better practice.用健康状态效用值填充经济模型:迈向更好的实践。
Value Health. 2010 Aug;13(5):509-18. doi: 10.1111/j.1524-4733.2010.00700.x. Epub 2010 Mar 10.
10
Patient-reported outcomes and the mandate of measurement.患者报告的结局与测量要求
Qual Life Res. 2008 Dec;17(10):1303-13. doi: 10.1007/s11136-008-9408-4. Epub 2008 Oct 25.